Enabling Informed Decisions in Breast Cancer through Information Technologies
Issue #6 June 2019
DESIREE 360º Breast Cancer Workshop
The DESIREE Project is happy to share information about a recent event organized in St. Louis Hospital in Paris, with the objective to showcase the DESIREE project and explore opportunities for the advanced decision-support platform for primary breast cancer. Going beyond the usual fragmented discussion on the breast cancer disease, the Workshop brought together representatives from:
Pharmaceutical industry, and particularly 5 top pharma companies leading BC treatment
Clinicians with year-long expertise in BC
Policy makers and influencers in BC management
Technology experts from the AI, big data and decision-making support field
Patient Association & Advocacy group representatives for BC
DESIREE Project Consortium members
Other external participants (e.g. Oncologists, Nurses)
The variety of the participant backgrounds and viewpoints and the invited speakers who brought in their wide experience in the field, consisted significant success factors and set an example for future activities.
Results of the DESIREE 360° Breast Cancer Workshop at a glance:
DESIREE decision-support system demonstrated and exposed to a wide, cross-functional audience of experts
Research, Clinicians & Medical community, Technology providers, Pharmaceutical Industry, Decision-makers and Patients came together around the same table to exchange on breast cancer
Mutually beneficial exchange and lobbying between all participating stakeholders
Experience exchange on big data management, security issues, patient data legislation, clinical decision-making practices, breast cancer management, personalized treatment and patient empowerment
The initiative and organization of the DESIREE 360° Breast Cancer Workshop belongs to the French team of the DESIREE Project Consortium, representing Assistance Publique – Hôpitaux de Paris (AP-HP) and INSERM Institute. All key BC stakeholder groups met at St. Louis Hospital in Paris, in Thursday, 28 March 2019 to exchange on common grounds.
DESIREE will help BC clinicians in their decision making process, with technology that includes advanced clinical decision support systems (based on formalized clinical guidelines, knowledge discovery, and case based reasoning), image-based breast and tumour characterization tools and predictive modeling for 3D breast reconstruction.
This project has received funding from the European Union's Horizon 2020 research and innovation programme under grant agreement No 690238
You are receiving this newsletter because you have subscribed through http://desiree-project.eu/ or a DESIREE partner. Should you wish to stop receiving this email newsletter, please click the Unsubscribe link below.